216 related articles for article (PubMed ID: 15121343)
1. Mood stabilizers: protecting the mood...protecting the brain.
Brunello N
J Affect Disord; 2004 Apr; 79 Suppl 1():S15-20. PubMed ID: 15121343
[TBL] [Abstract][Full Text] [Related]
2. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
3. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers.
Watson DG; Watterson JM; Lenox RH
J Pharmacol Exp Ther; 1998 Apr; 285(1):307-16. PubMed ID: 9536026
[TBL] [Abstract][Full Text] [Related]
4. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
Lenox RH; McNamara RK; Watterson JM; Watson DG
J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
[TBL] [Abstract][Full Text] [Related]
5. A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder.
McQuillin A; Rizig M; Gurling HM
Pharmacogenet Genomics; 2007 Aug; 17(8):605-17. PubMed ID: 17622937
[TBL] [Abstract][Full Text] [Related]
6. Valproate and neuroprotective effects for bipolar disorder.
Atmaca M
Int Rev Psychiatry; 2009; 21(4):410-3. PubMed ID: 20374154
[TBL] [Abstract][Full Text] [Related]
7. The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.
Gray NA; Zhou R; Du J; Moore GJ; Manji HK
J Clin Psychiatry; 2003; 64 Suppl 5():3-17. PubMed ID: 12720479
[TBL] [Abstract][Full Text] [Related]
8. Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders.
Brunello N; Tascedda F
Int J Neuropsychopharmacol; 2003 Jun; 6(2):181-9. PubMed ID: 12890311
[TBL] [Abstract][Full Text] [Related]
9. PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers.
Teo R; King J; Dalton E; Ryves J; Williams RS; Harwood AJ
Biochem Soc Trans; 2009 Oct; 37(Pt 5):1110-4. PubMed ID: 19754462
[TBL] [Abstract][Full Text] [Related]
10. The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior.
Shimshoni JA; Dalton EC; Jenkins A; Eyal S; Ewan K; Williams RS; Pessah N; Yagen B; Harwood AJ; Bialer M
Mol Pharmacol; 2007 Mar; 71(3):884-92. PubMed ID: 17167030
[TBL] [Abstract][Full Text] [Related]
11. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers.
Manji HK; Moore GJ; Chen G
Br J Psychiatry Suppl; 2001 Jun; 41():s107-19. PubMed ID: 11450170
[TBL] [Abstract][Full Text] [Related]
12. Mood stabilizers: shared mechanisms of action at postsynaptic signal-transduction and kindling processes.
Stoll AL; Severus WE
Harv Rev Psychiatry; 1996; 4(2):77-89. PubMed ID: 9384977
[TBL] [Abstract][Full Text] [Related]
13. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
Chuang DM
Ann N Y Acad Sci; 2005 Aug; 1053():195-204. PubMed ID: 16179524
[TBL] [Abstract][Full Text] [Related]
14. Valproate decreases inositol biosynthesis.
Shaltiel G; Shamir A; Shapiro J; Ding D; Dalton E; Bialer M; Harwood AJ; Belmaker RH; Greenberg ML; Agam G
Biol Psychiatry; 2004 Dec; 56(11):868-74. PubMed ID: 15576064
[TBL] [Abstract][Full Text] [Related]
15. Structure-function studies for the panacea, valproic acid.
Terbach N; Williams RS
Biochem Soc Trans; 2009 Oct; 37(Pt 5):1126-32. PubMed ID: 19754465
[TBL] [Abstract][Full Text] [Related]
16. How can the mood stabilizer VPA limit both mania and depression?
Cheng L; Lumb M; Polgár L; Mudge AW
Mol Cell Neurosci; 2005 Jun; 29(2):155-61. PubMed ID: 15911340
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons.
Di Daniel E; Mudge AW; Maycox PR
Bipolar Disord; 2005 Feb; 7(1):33-41. PubMed ID: 15654930
[TBL] [Abstract][Full Text] [Related]
18. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes.
Chen PS; Peng GS; Li G; Yang S; Wu X; Wang CC; Wilson B; Lu RB; Gean PW; Chuang DM; Hong JS
Mol Psychiatry; 2006 Dec; 11(12):1116-25. PubMed ID: 16969367
[TBL] [Abstract][Full Text] [Related]
19. Overview of the mechanism of action of lithium in the brain: fifty-year update.
Lenox RH; Hahn CG
J Clin Psychiatry; 2000; 61 Suppl 9():5-15. PubMed ID: 10826655
[TBL] [Abstract][Full Text] [Related]
20. The place of anticonvulsants and other putative mood stabilisers in the treatment of bipolar disorder.
Mitchell PB
Aust N Z J Psychiatry; 1999 Dec; 33 Suppl():S99-107. PubMed ID: 10622184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
